These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations. Novak A; Barad L; Lorber A; Gherghiceanu M; Reiter I; Eisen B; Eldor L; Itskovitz-Eldor J; Eldar M; Arad M; Binah O J Cell Mol Med; 2015 Aug; 19(8):2006-18. PubMed ID: 26153920 [TBL] [Abstract][Full Text] [Related]
7. Investigating Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639 [No Abstract] [Full Text] [Related]
8. Cronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Function. Zaunbrecher RJ; Abel AN; Beussman K; Leonard A; von Frieling-Salewsky M; Fields PA; Pabon L; Reinecke H; Yang X; Macadangdang J; Kim DH; Linke WA; Sniadecki NJ; Regnier M; Murry CE Circulation; 2019 Nov; 140(20):1647-1660. PubMed ID: 31587567 [TBL] [Abstract][Full Text] [Related]
9. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients. Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807 [TBL] [Abstract][Full Text] [Related]
10. Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy. Gramlich M; Pane LS; Zhou Q; Chen Z; Murgia M; Schötterl S; Goedel A; Metzger K; Brade T; Parrotta E; Schaller M; Gerull B; Thierfelder L; Aartsma-Rus A; Labeit S; Atherton JJ; McGaughran J; Harvey RP; Sinnecker D; Mann M; Laugwitz KL; Gawaz MP; Moretti A EMBO Mol Med; 2015 May; 7(5):562-76. PubMed ID: 25759365 [TBL] [Abstract][Full Text] [Related]
11. Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation. Vikhorev PG; Vikhoreva NN; Yeung W; Li A; Lal S; Dos Remedios CG; Blair CA; Guglin M; Campbell KS; Yacoub MH; de Tombe P; Marston SB Cardiovasc Res; 2022 Jan; 118(1):241-253. PubMed ID: 33135063 [TBL] [Abstract][Full Text] [Related]
12. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells. Wyles SP; Li X; Hrstka SC; Reyes S; Oommen S; Beraldi R; Edwards J; Terzic A; Olson TM; Nelson TJ Hum Mol Genet; 2016 Jan; 25(2):254-65. PubMed ID: 26604136 [TBL] [Abstract][Full Text] [Related]
13. A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism. Beqqali A; Bollen IA; Rasmussen TB; van den Hoogenhof MM; van Deutekom HW; Schafer S; Haas J; Meder B; Sørensen KE; van Oort RJ; Mogensen J; Hubner N; Creemers EE; van der Velden J; Pinto YM Cardiovasc Res; 2016 Oct; 112(1):452-63. PubMed ID: 27496873 [TBL] [Abstract][Full Text] [Related]
14. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884 [TBL] [Abstract][Full Text] [Related]
15. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs. Chen G; Li S; Karakikes I; Ren L; Chow MZ; Chopra A; Keung W; Yan B; Chan CW; Costa KD; Kong CW; Hajjar RJ; Chen CS; Li RA Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):193-202. PubMed ID: 25504561 [TBL] [Abstract][Full Text] [Related]
16. The assembly and evaluation of antisense oligonucleotides applied in exon skipping for titin-based mutations in dilated cardiomyopathy. Hahn JK; Neupane B; Pradhan K; Zhou Q; Testa L; Pelzl L; Maleck C; Gawaz M; Gramlich M J Mol Cell Cardiol; 2019 Jun; 131():12-19. PubMed ID: 30998980 [TBL] [Abstract][Full Text] [Related]
17. Titin-truncating variants in hiPSC cardiomyocytes induce pathogenic proteinopathy and sarcomere defects with preserved core contractile machinery. Huang G; Bisaria A; Wakefield DL; Yamawaki TM; Luo X; Zhang JA; Vigneault P; Wang J; Reagan JD; Oliverio O; Zhou H; Li CM; Vila OF; Wang S; Malik FI; Hartman JJ; Hale CM Stem Cell Reports; 2023 Jan; 18(1):220-236. PubMed ID: 36525964 [TBL] [Abstract][Full Text] [Related]
18. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Tse HF; Ho JC; Choi SW; Lee YK; Butler AW; Ng KM; Siu CW; Simpson MA; Lai WH; Chan YC; Au KW; Zhang J; Lay KW; Esteban MA; Nicholls JM; Colman A; Sham PC Hum Mol Genet; 2013 Apr; 22(7):1395-403. PubMed ID: 23300193 [TBL] [Abstract][Full Text] [Related]
19. Titin mutations: the fall of Goliath. Neiva-Sousa M; Almeida-Coelho J; Falcão-Pires I; Leite-Moreira AF Heart Fail Rev; 2015 Sep; 20(5):579-88. PubMed ID: 26024954 [TBL] [Abstract][Full Text] [Related]